{{Rsnum
|rsid=2472299
|Chromosome=15
|position=74741059
|Orientation=plus
|GMAF=0.3503
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 8.8 | 37.2 | 54.0
| HCB | 9.5 | 45.3 | 45.3
| JPT | 15.9 | 47.8 | 36.3
| YRI | 17.1 | 50.0 | 32.9
| ASW | 7.0 | 49.1 | 43.9
| CHB | 9.5 | 45.3 | 45.3
| CHD | 15.6 | 48.6 | 35.8
| GIH | 22.8 | 50.5 | 26.7
| LWK | 25.5 | 54.5 | 20.0
| MEX | 12.1 | 29.3 | 58.6
| MKK | 23.1 | 48.7 | 28.2
| TSI | 13.7 | 47.1 | 39.2
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21378988
|Trait=None
|Title=A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease
|RiskAllele=
|Pval=0.000003
|OR=None
|ORtxt=None
}}

{{PMID Auto
|PMID=22648710
|Title=CYP1A2 and coffee intake and the modifying effect of sex, age, and smoking
}}

{{PMID Auto
|PMID=18268125
|Title=Assessment of interactions between PAH exposure and genetic polymorphisms on PAH-DNA adducts in African American, Dominican, and Caucasian mothers and newborns.
|OA=1
}}

{{PMID Auto
|PMID=18632753
|Title=Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes.
|OA=1
}}

{{PMID Auto
|PMID=18691756
|Title=Paternal smoking, genetic polymorphisms in CYP1A1 and childhood leukemia risk.
|OA=1
}}

{{PMID Auto
|PMID=18798002
|Title=Coffee consumption, genetic susceptibility and bladder cancer risk.
|OA=1
}}

{{PMID Auto
|PMID=18936436
|Title=Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey, 1991-1994.
|OA=1
}}

{{PMID Auto
|PMID=19479063
|Title=Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}